CVA Family Office’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Buy
6,494
+202
+3% +$45.2K 0.15% 92
2025
Q4
$1.08M Buy
6,292
+34
+0.5% +$5.29K 0.12% 100
2025
Q3
$838K Buy
6,258
+9
+0.1% +$953 0.11% 116
2025
Q2
$608K Sell
6,249
-37
-0.6% -$2.94K 0.09% 146
2025
Q1
$457K Sell
6,286
-145
-2% -$11.4K 0.07% 177
2024
Q4
$465K Buy
6,431
+721
+13% +$54.7K 0.07% 167
2024
Q3
$466K Hold
5,710
0.08% 157
2024
Q2
$608K Buy
5,710
+60
+1% +$5.75K 0.11% 125
2024
Q1
$549K Buy
5,650
+10
+0.2% +$880 0.1% 131
2023
Q4
$442K Hold
5,640
0.09% 144
2023
Q3
$353K Hold
5,640
0.08% 151
2023
Q2
$363K Buy
5,640
+120
+2% +$6.76K 0.08% 154
2023
Q1
$293K Sell
5,520
-160
-3% -$7.85K 0.07% 171
2022
Q4
$239K Buy
5,680
+1,830
+48% +$76.5K 0.06% 179
2022
Q3
$141K Buy
3,850
+2,400
+166% +$107K 0.04% 203
2022
Q2
$62K Buy
1,450
+250
+21% +$11.9K 0.02% 319
2022
Q1
$65K Sell
1,200
-600
-33% -$34.9K 0.02% 344
2021
Q4
$129K Buy
+1,800
New +$113K 0.03% 208
2021
Q3
Sell
-1,850
Closed -$120K 646
2021
Q2
$120K Buy
1,850
+650
+54% +$41K 0.03% 216
2021
Q1
$71K Buy
+1,200
New +$65.4K 0.03% 231

Other funds holding LRCX

CVA Family Office's LRCX Position: Q1 2026 in Review

CVA Family Office increased its Lam Research (LRCX) stake by 3.2% in Q1 2026, buying an estimated $45.2K and bringing the position to 6,494 shares worth $1.39M. The position accounts for 0.15% of the portfolio, ranked #92.

CVA Family Office first reported a position in LRCX in Q1 2021 and has held it in 20 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • CVA Family Office held 6,494 shares of Lam Research worth $1.39M as of Q1 2026.
  • CVA Family Office bought 202 Lam Research shares in Q1 2026, an estimated $45.2K.
  • Lam Research made up 0.15% of CVA Family Office's portfolio in Q1 2026, its #92 holding.
  • CVA Family Office first reported a position in Lam Research in Q1 2021 and has held it in 20 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.